BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35746861)

  • 1. Lanbotulinumtoxin-A: Safe for children with cerebral palsy but is it effective?
    Hastings-Ison T; Graham K
    Dev Med Child Neurol; 2023 Jan; 65(1):10-11. PubMed ID: 35746861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse events after different forms of botulinum neurotoxin A injections in children with cerebral palsy: An 8-year retrospective study.
    Li J; He L; Tang H; Peng T; Long Y; Zeng P; Huang Y; Chen Z; Han M; Xu K
    Dev Med Child Neurol; 2023 Jan; 65(1):86-93. PubMed ID: 35674175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with botulinum toxin in the treatment of cerebral palsy.
    Arens LJ; Leary PM; Goldschmidt RB
    S Afr Med J; 1997 Aug; 87(8):1001-3. PubMed ID: 9323408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of botulinum toxin A in management of children with cerebral palsy.
    Friedman BC; Goldman RD
    Can Fam Physician; 2011 Sep; 57(9):1006-73. PubMed ID: 21918142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How safe and effective is the use of bisphosphonates in the treatment of osteoporosis in children with cerebral palsy? A Cochrane Review summary with commentary.
    Arman S
    Dev Med Child Neurol; 2022 Mar; 64(3):286-288. PubMed ID: 35040137
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of Risperidone on the Motor and Functional Disability in Children With Choreoathetoid Cerebral Palsy.
    Kamate M; Mittal N; Metgud D
    Pediatr Neurol; 2018 Jul; 84():46-48. PubMed ID: 29859722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Botulinum toxin A in children with infantile cerebral palsy: indications and treatment concepts].
    Placzek R
    Orthopade; 2010 Jan; 39(1):23-30. PubMed ID: 20033394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of serial injections of botulinum toxin A in children with spastic cerebral palsy.
    Wang YJ; Gao BQ
    World J Pediatr; 2013 Nov; 9(4):342-5. PubMed ID: 24235067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of sirdalud in cerebral palsy in children].
    Brin IL; Kurenkov AL; Gotlib VIa
    Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(10):30-3. PubMed ID: 10536809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of diazepam on athetosic children with cerebral palsy].
    Claverie P; Ousset A; Cahusac M; Nichil J; Bayrou
    Rev Neuropsychiatr Infant; 1968 Dec; 16(12):925-30. PubMed ID: 5714897
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of the hyperkinetic form of cerebral palsy in children].
    Mel'nichuk PV; Sosnovskaia LS; Khaĭlova IM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(10):1463-7. PubMed ID: 1210919
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of intramuscular botulinum toxin in Malaysian children with cerebral palsy.
    Khoo TB; Yusniza MY; Chern PM
    Med J Malaysia; 2007 Mar; 62(1):3-5. PubMed ID: 17682560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin in children with cerebral palsy.
    Singhi P; Ray M
    Indian J Pediatr; 2004 Dec; 71(12):1087-91. PubMed ID: 15630317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of toxin botulin on walk stereotype of children with juvenile cerebral palsy. The functional examination performed by BTS, comprehensive movement analysis system. A preliminary report].
    Kwiecień-Czerwieniec I; Krukowska J; Woldańska-Okońska M
    Wiad Lek; 2014; 67(2 Pt 1):59-63. PubMed ID: 25764777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does botulinum toxin prevent or promote deformity in children with cerebral palsy?
    Gough M
    Dev Med Child Neurol; 2009 Feb; 51(2):89-90. PubMed ID: 19191839
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of children with cerebral palsy.
    Dai AI
    J Pediatr Orthop B; 2007 Jul; 16(4):303. PubMed ID: 17527111
    [No Abstract]   [Full Text] [Related]  

  • 17. Bone densitometry in pediatric patients treated with pamidronate.
    Grissom LE; Kecskemethy HH; Bachrach SJ; McKay C; Harcke HT
    Pediatr Radiol; 2005 May; 35(5):511-7. PubMed ID: 15655696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic review.
    Boyd RN; Hays RM
    Eur J Neurol; 2001 Nov; 8 Suppl 5():1-20. PubMed ID: 11851730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of benzhexol hydrochloride to control drooling of children with cerebral palsy.
    Reddihough D; Johnson H; Staples M; Hudson I; Exarchos H
    Dev Med Child Neurol; 1990 Nov; 32(11):985-9. PubMed ID: 2269408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin-induced cluster of seizures in two children with cerebral palsy.
    Tatlı B; Bozgan D; Ekici B; Gürbüzer CA
    Acta Neurol Belg; 2020 Aug; 120(4):969-970. PubMed ID: 31555981
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.